Science Corporation's banner

Science Corporation

@ScienceCorp_ • 4,020 subscribers

Building a brighter tomorrow enabled by neural engineering

Videos

Anya Rossi

sweetdream.ai

SweetDream.ai•Sponsored•Livecam

Watch Anya Live

Anya is streaming live right now! Join her private show and enjoy exclusive content.

Exclusive private shows

1.2k viewers online

Private Show

Join now for exclusive access

Free preview available • Premium content

We're designing implants to live inside the body for decades. Accelerated lifetime testing compresses years of testing into weeks; it validates that our devices can survive in vivo conditions long term.

We're designing implants to live inside the body for decades. Accelerated lifetime testing compresses years of testing into weeks; it validates that our devices can survive in vivo conditions long term.

Science Corporation

20,075 次观看 • 23 天前

Watch a neural recording system small enough to fit in your pocket get built.

Watch a neural recording system small enough to fit in your pocket get built.

Science Corporation

20,640 次观看 • 2 个月前

The New England Journal of Medicine (NEJM) today published a peer-reviewed original paper with the results of a landmark clinical trial of our PRIMA brain-computer interface (BCI) retinal implant.

The New England Journal of Medicine (NEJM) today published a peer-reviewed original paper with the results of a landmark clinical trial of our PRIMA brain-computer interface (BCI) retinal implant.

Science Corporation

29,335 次观看 • 10 个月前

BBC News (UK) followed one of the patients at Moorfields Eye Hospital NHS Foundation Trust in London who participated in our landmark clinical trial of PRIMA. She began losing her sight more than three decades ago due to age-related macular degeneration. Now she can read again for the first time in years. NEJM published the results of this trial yesterday in a new peer-reviewed original paper.

BBC News (UK) followed one of the patients at Moorfields Eye Hospital NHS Foundation Trust in London who participated in our landmark clinical trial of PRIMA. She began losing her sight more than three decades ago due to age-related macular degeneration. Now she can read again for the first time in years. NEJM published the results of this trial yesterday in a new peer-reviewed original paper.

Science Corporation

14,867 次观看 • 10 个月前

没有更多内容可加载